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tients between January 2008 and September 2013. Eligible patients
had a primary procedure for an interventional or diagnostic CV
procedure deﬁned by ICD-9 and/or Current Procedural Terminology
(CPT) codes, inpatient admission, and LOCM or iso-osmolar CM
agent. CM agents were identiﬁed by Standard Charge Master codes
and text mining algorithms. One iso-osmolar CM, iodixanol, was
identiﬁed. Six LOCMs were identiﬁed: iohexol, ioversol, iopamidol,
ioxaglate, ioxilan, and iopromide. AKI and CIAKI events were
determined by ICD-9 diagnosis codes. Multivariable regression
analysis was conducted using Ordinary Least Square (OLS) and
hospital ﬁxed-effects speciﬁcations to assess the relationship be-
tween the CM used and CIAKI events for patients with an AKI
event.
RESULTS A total of 385,290 interventional and 277,009 diagnostic
CV procedure visits were identiﬁed. Iso-osmolar CM was used more
in older interventional patients (67.0 vs. 63.8; p<0.0001) and in
older diagnostic patients (66.0 vs. 61.7; p <0.0001) compared to
LOCM. In both populations, patients receiving iso-osmolar CM were
sicker as measured by Charlson Comorbidity Index Score compared
to patients receiving LOCM (3.9 vs. 3.4; p<0.0001, & 3.9 vs. 3.2;
p<0.0001 for interventional and diagnostic, respectively). Of all
patients, 22,925 interventional and 20,635 diagnostic had an AKI.
Within this group, 1,539 interventional and 807 diagnostic patients
had their AKI classiﬁed as a CIAKI. Univariate OLS analysis indi-
cated that patients receiving an iso-osmolar CM had 0.8% (p<0.05)
and 0.2% (p NS) fewer CIAKI events compared to a LOCM for
interventional and diagnostic procedures, respectively. Controlling
for detailed patient characteristics and time-invariant unobserved
heterogeneity across hospitals using hospital ﬁxed-effects resulted
in 1.24% (p < 0.01) and 1.0% (p<0.01) fewer CIAKI events with iso-
osmolar CM for interventional and diagnostic procedures, respec-
tively. These absolute reductions represented 18% and 25% relative
reductions for overall interventional and diagnostic populations,
respectively.
CONCLUSIONS In this retrospective study of patients with a record of
AKI, the use of iso-osmolar CM was associated with fewer CIAKI
events compared to LOCMs for patients undergoing inpatient inter-
ventional or diagnostic CV procedures.
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BACKGROUND Chronic kidney disease (CKD) and diabetes mellitus
(DM) are associated with increased risk of adverse events in pa-
tients with drug eluting stents (DES). Prior studies were con-
ducted on predominantly male patient populations; thus the
effect of CKD and DM on outcomes in women with DES remains
unclear.
METHODS The purpose of this study was to characterize the in-
dependent and combined impact of CKD and DM on outcomes in
women undergoing DES implantation. We pooled patient-level
data from 26 randomized controlled trials of DES. The primary
outcomes of interest were all-cause mortality and major adversecardiac event (MACE) deﬁned as the composite of all-cause mor-
tality, myocardial infarction or stent thrombosis, at 3 years after
DES placement. The study population was stratiﬁed into 4 groups:
women with neither DM nor CKD, those with DM and no CKD,
those with CKD and no DM, and those with both DM and CKD.
Women who received a bare metal stent were excluded from this
analysis.
RESULTS Out of 4210 women in the pooled dataset for whom
baseline creatinine levels were available, 1794 (43.0%) had neither
DM nor CKD, 965 (23.0%) had CKD alone, 972 (23.0%) had DM
alone, and 479 (11.0%) had both DM and CKD. A stepwise increase
in 3-year crude event rates was observed in the transition from
no CKD or DM, DM alone, CKD alone,to both CKD and DM
(Figure 1).Following multivariable adjustment, hazard ratios (HR)
for all-cause mortality were: 1.81 (95% CI: 1.20 – 2.73) in patients
with DM alone, 1.38 (95% CI: 0.93 – 2.07) in patients with CKD
alone, and 3.49 (95% CI: 2.33 – 5.23) in patients with both CKD
and DM (trend p value <0.0001). Conversely, the adjusted HRs for
MACE were 1.24 (95% CI: 0.94-1.64) in patients with DM alone,
1.01 (95% CI: 0.76 – 1.34) in patients with CKD alone, and 2.18
(95% CI: 1.63-2.92) in patients with both CKD and DM (trend
p value<0.0001).CONCLUSIONS The presence of both CKD and DM confers a syner-
gistic adverse effect on the risk for long-term MACE in women un-
dergoing PCI.
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BACKGROUND Contrast-induced acute kidney injury (CIAKI) is a
common complication of coronary catheterization. Although several
strategies have been proposed, the real efﬁcacy in reducing CIAKI
of most of these is debated. We pooled data from randomized
trials comparing different preventive strategies for CIAKI in pa-
tients undergoing coronary catheterization to deﬁne the relative
efﬁcacy.
METHODS Randomized trials comparing 2 different strategies
were searched in major scientiﬁc databases. Trials including pa-
tients undergoing procedures requiring contrast media different
